Tokyo, Oct. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059721) titled 'A study on the effects of cucumber extract intake on the physical and mental health of healthy adults' on Oct. 13.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - others

Condition: Condition - Healthy adult Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To examine the effects of cucumber extract intake on the mind and body Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Participants will consume the test food for 4 weeks. They will take one packet per day with water or lukewarm water. Interventions/Control_2 - Participants will consume the placebo for 4 weeks. They will take one packet per day with water or lukewarm water.

Eligibility: Age-lower limit - 18 years-old

Gender - Male and Female Key inclusion criteria - (1) Individuals who are generally considered to be healthy (2) Those who are aware of joint pain, physical and mental fatigue, or stress (3) Individuals who can give voluntary written consent to participate in the present trial Key exclusion criteria - (1) Individuals who regularly consume any dietary supplements, quasi-drugs, or medicines that have the same or similar effects as those evaluated in this study (2) Individuals who have changed or newly started taking health foods or dietary supplements within the past 4 weeks (3) Individuals who work night shifts or rotating shifts (4) Individuals receiving medical or preventive treatment (e.g., hormone replacement, pharmacotherapy, exercise, or dietary therapy) at the time of obtaining informed consent, or judged to require such treatment (5) Individuals with a history of serious metabolic, hepatic, renal, cardiovascular, respiratory, endocrine, immune, neurological, or psychiatric disorders. (6) Individuals with a medical history of alcohol or drug dependence (7) Individuals who might develop an allergic reaction to foods (8) Individuals who are pregnant, breastfeeding, or intend to become pregnant during the study period (9) Individuals who have participated in any other human study involving foods, medicines, quasi-drugs, or medical devices within the past 4 weeks, or who plan to participate in another study during the study period (10) Individuals who are judged by the investigator to be unsuitable for participation in the study Target Size - 30

Recruitment Status: Recruitment status - Completed Date of protocol fixation - 2025 Year 10 Month 31 Day Date of IRB - 2025 Year 03 Month 11 Day Anticipated trial start date - 2025 Year 11 Month 11 Day Last follow-up date - 2025 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068302

Disclaimer: Curated by HT Syndication.